Time2OwnIt is a digital prostate-health platform designed to support earlier awareness, clearer risk understanding, and timely access to appropriate care, particularly for men and anyone with a prostate who may be at higher risk or underserved by traditional pathways.
We believe everyone with a prostate should have the knowledge, confidence, and support to take action on their health earlier, before symptoms appear and when timely clinical engagement can improve outcomes.
Black men experience a significantly higher risk of prostate cancer compared with the general population.
Men living in more deprived areas are more likely to be diagnosed at an advanced stage of disease.
Unlike some other cancers, there is currently no population-wide screening programme for prostate cancer in the UK.
Current PSA testing has recognised limitations that can affect accuracy and clinical interpretation.
We are here for men and anyone with a prostate who want to take control of their prostate health journey earlier.
When proactive awareness and monitoring become most valuable.
Including those with close relatives who have experienced the disease.
Including Black men and those living in more deprived areas.
Supporting earlier understanding and informed next steps.
Time2OwnIt supports informed health decisions while ensuring clinical care remains with qualified healthcare professionals.
Time2OwnIt provides education, risk awareness, and guided next steps, while clinical care always remains with qualified healthcare professionals.
Access clear, evidence-informed information about prostate health and recognised risk factors.
Use structured tools to explore your individual risk profile and level of awareness.
Receive clear guidance on possible next steps and when to seek professional medical advice.
Connect with appropriate, accredited healthcare providers where further assessment may be needed.
Access continued information, resources, and support throughout your prostate-health journey.
When prostate cancer is detected early, nearly all men or anyone with a prostate survive for five years or more, compared with around half when diagnosed at an advanced stage. Earlier detection is strongly associated with better outcomes.
5-year survival when detected early.
5-year survival when diagnosed at a later stage.
We are committed to high standards of data protection, clinical safety, and responsible digital-health governance.
Our clinical advisory input includes experienced healthcare specialists across:
Founder & CEO
Healthcare leader with extensive experience in NHS diagnostics, digital transformation, and clinical-service innovation, leading the strategic vision and delivery of Time2OwnIt.
Co-Founder & Chief Digital Officer (CDO)
Cyber security and cloud infrastructure specialist with expertise in SecOps, platform security, and technical risk management. At Time2OwnIt, Ayush leads infrastructure security and risk mitigation while helping shape the company's technology and business strategy.
Co-Founder & Chief Technology Officer (CTO)
Software engineer with 10+ years across FinTech, video streaming, and e-commerce. At Time2OwnIt, Geoffrey leads platform development and all technical operations, including CI/CD and DevOps.
Take the assessment or learn more about prostate health.